Evaluating Metacognitive Therapy to Improve Treatment of Anxiety and Depression in Cardiovascular Disease: The NIHR Funded PATHWAY Research Programme

mctpapertier 3link ok

Open source

ID
0bebbc4e61314a5e
Source org
PubMed Central
Author
Published
OA status
DOI
10.3389/fpsyt.2022.886407
PMID
PMCID
PMC12275460
Citations

Tags

Verification

Automated checks only — not clinical endorsement or advice.

Cite this entry

BibTeX

@article{allodium:0bebbc4e61314a5e,
  title = {Evaluating Metacognitive Therapy to Improve Treatment of Anxiety and Depression in Cardiovascular Disease: The NIHR Funded PATHWAY Research Programme},
  journal = {PubMed Central},
  doi = {10.3389/fpsyt.2022.886407},
  url = {https://doi.org/10.3389/fpsyt.2022.886407}
}

RIS

TY  - JOUR
TI  - Evaluating Metacognitive Therapy to Improve Treatment of Anxiety and Depression in Cardiovascular Disease: The NIHR Funded PATHWAY Research Programme
PB  - PubMed Central
DO  - 10.3389/fpsyt.2022.886407
UR  - https://doi.org/10.3389/fpsyt.2022.886407
ER  - 

APA

Evaluating Metacognitive Therapy to Improve Treatment of Anxiety and Depression in Cardiovascular Disease: The NIHR Funded PATHWAY Research Programme. (n.d.). PubMed Central. https://doi.org/10.3389/fpsyt.2022.886407

Related entries